Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
i3 Energy PLC (T.ITE) Announces February 2023 Dividend Declaration (click to learn more) Canada Nickel Announces $24 million Investment from Anglo American (click to learn more) GFI Announces Launch at Sprouts Farmers Market (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ardelyx Inc. ARDX

Healthcare Biotechnology
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with...


NDAQ:ARDX - Post by User

Ardelyx Inc.
Bullboard Posts
Next >>
User Avatar Image
(75)
•••
  • IseneschalX
Post by Iseneschalon Nov 17, 2022 6:53am
107 Views
Post# 35105893

ARDX ...... Halted yesterday a.m and resumed AH

ARDX ...... Halted yesterday a.m and resumed AHClosed up 82 cents in yesterdays After Hours trading and is cintinuing this a.m in the Pre Market open.

News yesterday........

Ardelyx Announces FDA Advisory Committee Votes that the Benefits of XPHOZAH ‚ ® (tenapanor) Outweigh its Risks for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

2022-11-16 15:29 PT - News Release

WALTHAM, Mass.

Bullboard Posts
Next >>